Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 23, 2023 14:05 ET | Source: Oxurion NV

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 8 convertible bonds in Oxurion resulting in a EUR 200,000 capital increase. This is part of Atlas Special...
August 23, 2023 14:00 ET | Source: Oxurion NV

Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC

Regulated Information Leuven, BELGIUM, Boston, MA, US – August 23, 2023 – 8.00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care...
August 21, 2023 13:05 ET | Source: Oxurion NV

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase. This is part of Atlas Special...
August 21, 2023 13:00 ET | Source: Oxurion NV

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Regulated Information Leuven, BELGIUM, Boston, MA, US – August 21, 2023 – 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care...
August 16, 2023 13:00 ET | Source: Oxurion NV

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Regulated Information Leuven, BELGIUM, Boston, MA, US – August 16, 2023 – 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care...
August 11, 2023 02:08 ET | Source: Oxurion NV

Oxurion Receives Funding of EUR One Million under Atlas Special Opportunities LLC (Atlas) Funding Program

Leuven, BELGIUM, Boston, MA, US – August 11, 2023 – 8 am CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next-generation standard of care ophthalmic therapies, with...
August 11, 2023 02:05 ET | Source: Oxurion NV

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase. This is part of Atlas Special...
August 11, 2023 02:00 ET | Source: Oxurion NV

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Regulated Information Leuven, BELGIUM, Boston, MA, US – August 11, 2023 – 8.00 AM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care...
August 07, 2023 13:05 ET | Source: Oxurion NV

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 8 convertible bonds in Oxurion resulting in a EUR 200,000 capital increase. This is part of Atlas Special...
August 07, 2023 13:00 ET | Source: Oxurion NV

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Regulated Information Leuven, BELGIUM, Boston, MA, US – August 7, 2023 – 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care...